{"id":"angiotensin-receptor-blocker","safety":{"commonSideEffects":[{"rate":"5-10","effect":"Dizziness"},{"rate":"3-8","effect":"Fatigue"},{"rate":"2-5","effect":"Hyperkalemia"},{"rate":"1-3","effect":"Cough"},{"rate":"2-5","effect":"Hypotension"}]},"_chembl":{"chemblId":"CHEMBL1402326","moleculeType":"Small molecule","molecularWeight":"540.13"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"ARBs selectively antagonize the AT1 receptor on vascular smooth muscle and adrenal tissue, blocking the effects of angiotensin II. This prevents vasoconstriction, reduces aldosterone-mediated sodium and water retention, and decreases sympathetic nervous system activation. The result is reduced peripheral vascular resistance and lower blood pressure.","oneSentence":"Angiotensin receptor blockers block the angiotensin II type 1 receptor, preventing vasoconstriction and aldosterone release to lower blood pressure.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:27:17.947Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Heart failure with reduced ejection fraction"},{"name":"Diabetic nephropathy"},{"name":"Post-myocardial infarction"}]},"trialDetails":[{"nctId":"NCT05168787","phase":"","title":"Efficacy and Safety of Sacubitril/Valsartan in African American Patients With Heart Failure With Reduced Ejection Fraction","status":"COMPLETED","sponsor":"Methodist Health System","startDate":"2020-08-13","conditions":"Heart Failure","enrollment":6558},{"nctId":"NCT05457283","phase":"PHASE3","title":"A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria","status":"RECRUITING","sponsor":"Bayer","startDate":"2022-11-08","conditions":"Chronic Kidney Disease, Proteinuria, Children","enrollment":100},{"nctId":"NCT04789733","phase":"NA","title":"The GUARDIAN Pilot Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2021-04-27","conditions":"General Surgery","enrollment":80},{"nctId":"NCT06975111","phase":"PHASE2, PHASE3","title":"Focusing on the Menopausal Transition to Improve Mid-Life Women's Health","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-03-01","conditions":"Menopause, Menopause Hot Flashes, Menopause Related Conditions","enrollment":200},{"nctId":"NCT04456816","phase":"PHASE2","title":"A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria","status":"RECRUITING","sponsor":"SynAct Pharma Aps","startDate":"2020-08-31","conditions":"Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy, Severe Proteinuria Due to Idiopathic Membranous Nephropathy","enrollment":23},{"nctId":"NCT07447206","phase":"PHASE2","title":"Vascular Intervention Strategies Trial for Alzheimer's","status":"NOT_YET_RECRUITING","sponsor":"University of Southern California","startDate":"2026-03","conditions":"Hypertension, Hypercholesterolemia, Dementia Risk Factors","enrollment":10},{"nctId":"NCT07167368","phase":"NA","title":"Exercise Rehabilitation for Cardiorenal Syndrome in HFrEF Patients","status":"RECRUITING","sponsor":"Haiyan Pan","startDate":"2025-09-15","conditions":"Cardiorenal Syndrome","enrollment":60},{"nctId":"NCT07292493","phase":"","title":"Immune System in Diabetic Kidney Disease","status":"ENROLLING_BY_INVITATION","sponsor":"University Medical Centre Ljubljana","startDate":"2025-12-01","conditions":"Diabetes, Diabetic Kidney Disease, Complement System","enrollment":90},{"nctId":"NCT03417388","phase":"PHASE4","title":"Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2018-02-09","conditions":"Coronary Artery Disease","enrollment":2476},{"nctId":"NCT07044700","phase":"","title":"Real-world Comparative Effectiveness and Safety of Jardiance in Chinese Patients With Heart Failure of Reduced Ejection Fraction","status":"NOT_YET_RECRUITING","sponsor":"Boehringer Ingelheim","startDate":"2028-01-31","conditions":"Heart Failure of Reduced Ejection Fraction (HFrEF)","enrollment":5000},{"nctId":"NCT07099677","phase":"NA","title":"Short-Term Effects of Antihypertensive Drugs on Postural Balance and Fall Risk","status":"RECRUITING","sponsor":"Abant Izzet Baysal University","startDate":"2025-08-01","conditions":"Hypertension, Fall Risk, Postural Balance","enrollment":186},{"nctId":"NCT05196035","phase":"PHASE3","title":"A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria","status":"RECRUITING","sponsor":"Bayer","startDate":"2022-03-28","conditions":"Chronic Kidney Disease, Proteinuria","enrollment":219},{"nctId":"NCT05183646","phase":"PHASE3","title":"A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB","status":"RECRUITING","sponsor":"Dimerix Bioscience Pty Ltd","startDate":"2022-05-30","conditions":"FSGS","enrollment":286},{"nctId":"NCT04591210","phase":"PHASE3","title":"The COVID-RASi Trial (COVID-19)","status":"COMPLETED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2021-01-27","conditions":"COVID-19, Cardiovascular Diseases","enrollment":372},{"nctId":"NCT04849806","phase":"","title":"Sympathetic Nerve Activity Predictors in Patients With Chronic Obstructive Pulmonary Disease","status":"RECRUITING","sponsor":"RWTH Aachen University","startDate":"2022-05-10","conditions":"COPD, Sympathetic Nervous System Diseases, Catecholamine; Overproduction","enrollment":135},{"nctId":"NCT07349979","phase":"NA","title":"PCI With Guideline-Directed Medical Therapy for HFpEF Patients With Ischemic Cardiomyopathy","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2026-01-30","conditions":"Heart Failure With Reduced Ejection Fraction, Coronary Artery Disease","enrollment":654},{"nctId":"NCT05834803","phase":"NA","title":"Effects of Percutaneous Transluminal Renal Angioplasty of Atherosclerotic Renal Artery Stenosis in High-Risk Patients.","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2023-06-26","conditions":"Renovascular Hypertension, Renovascular Hypertension With Renal Failure, Heart Failure","enrollment":80},{"nctId":"NCT06023576","phase":"PHASE2","title":"A Study of Blood Pressure Control During Cancer Treatment","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-08-18","conditions":"Breast Cancer, Cardiotoxicity","enrollment":130},{"nctId":"NCT05764057","phase":"PHASE3","title":"DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-06-12","conditions":"AMI, STEMI, NSTEMI","enrollment":450},{"nctId":"NCT07295522","phase":"PHASE4","title":"Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap?","status":"NOT_YET_RECRUITING","sponsor":"IRCCS Policlinico S. Donato","startDate":"2026-01-08","conditions":"Heart Failure, Acute Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF)","enrollment":368},{"nctId":"NCT02770066","phase":"","title":"A Prospective Danish National Registry of PTRA in Patients With Renovascular Hypertension","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2015-01-01","conditions":"Renal Artery Obstruction, Hypertension, Renovascular, Cardiovascular Diseases","enrollment":160},{"nctId":"NCT07262710","phase":"","title":"Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study","status":"NOT_YET_RECRUITING","sponsor":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","startDate":"2025-12-01","conditions":"Post-stroke Pneumonia","enrollment":13656},{"nctId":"NCT07261098","phase":"PHASE2","title":"The Efficacy and Safety of ARNI on the Outcome of Advanced Lung Cancer With Concurrent Hypertension","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Chest Hospital","startDate":"2026-01-01","conditions":"Advanced Lung Cancer","enrollment":200},{"nctId":"NCT05106036","phase":"NA","title":"Preventing Cognitive Decline by Reducing BP Target Trial","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2022-07-11","conditions":"Cognitive Decline, Blood Pressure, Hypertension","enrollment":4000},{"nctId":"NCT06183437","phase":"PHASE4","title":"The STOP-MED CTRCD Trial","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2024-03-04","conditions":"Heart Failure, Cardiotoxicity, Cardiac Toxicity","enrollment":335},{"nctId":"NCT07241338","phase":"PHASE4","title":"Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity","status":"NOT_YET_RECRUITING","sponsor":"Jing Liu","startDate":"2025-11","conditions":"Hypertension","enrollment":104},{"nctId":"NCT05180773","phase":"PHASE4","title":"Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy","status":"RECRUITING","sponsor":"Dennis M. McNamara, MD, MS","startDate":"2022-07-27","conditions":"Peripartum Cardiomyopathy, Postpartum","enrollment":250},{"nctId":"NCT05272878","phase":"PHASE3","title":"Impact of a Treatment With Angiotensin Receptor Blocker on Outcome After Acute Kidney Injury in Patients Discharged From the ICU.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-11-22","conditions":"Acute Kidney Injury","enrollment":508},{"nctId":"NCT02472028","phase":"PHASE4","title":"Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-09","conditions":"Cerebrovascular Disorders","enrollment":820},{"nctId":"NCT04884802","phase":"NA","title":"The GUARDIAN Trial","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2021-07-25","conditions":"Blood Pressure","enrollment":6254},{"nctId":"NCT06704633","phase":"PHASE4","title":"Sacubitril-valsartan in Patients With Heart Failure With Reduced Ejection Fraction From Rural Tanzania","status":"NOT_YET_RECRUITING","sponsor":"Martin Rohacek","startDate":"2026-01-05","conditions":"Heart Failure","enrollment":238},{"nctId":"NCT03733145","phase":"PHASE4","title":"Angiotensin II in General Anesthesia","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2019-10-03","conditions":"Hypertension","enrollment":32},{"nctId":"NCT07088471","phase":"","title":"Cardiac Left Atrial Evaluation and Response in HFrEF With Sacubitril/Valsartan","status":"ACTIVE_NOT_RECRUITING","sponsor":"Connolly Hospital Blanchardstown","startDate":"2024-11-01","conditions":"Heart Failure and Reduced Ejection Fraction","enrollment":334},{"nctId":"NCT05331144","phase":"PHASE2","title":"Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)","status":"RECRUITING","sponsor":"Rong Zhang","startDate":"2022-10-25","conditions":"Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline","enrollment":180},{"nctId":"NCT06150560","phase":"PHASE3","title":"A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-04-01","conditions":"Coarctation of Aorta, High Blood Pressure","enrollment":120},{"nctId":"NCT07098897","phase":"PHASE3","title":"To Evaluate the Effect and Safety of Telitacicept and Standard Treatment for 6months in IgA Nephropathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Affiliated Hospital of Xuzhou Medical University","startDate":"2024-08-01","conditions":"IgA Nephropathy (IgAN)","enrollment":150},{"nctId":"NCT05806138","phase":"PHASE2","title":"A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-07-17","conditions":"Breast Cancer, Cardiac Dysfunction","enrollment":21},{"nctId":"NCT02373163","phase":"PHASE4","title":"INTERVENCION Trial","status":"COMPLETED","sponsor":"Prevencion","startDate":"2014-09-01","conditions":"Blood Pressure, High","enrollment":166},{"nctId":"NCT04715568","phase":"PHASE4","title":"Secondhand Tobacco Smoke and Cardiovascular Disease","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2021-03-30","conditions":"Cardiovascular Diseases, Hypertension","enrollment":100},{"nctId":"NCT05237323","phase":"PHASE3","title":"Micophenolate Mofetil Versus Azathioprine in Myocarditis","status":"COMPLETED","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2020-10-01","conditions":"Lymphocytic Myocarditis (Disorder), Heart Failure, Dilated Cardiomyopathy","enrollment":50},{"nctId":"NCT06676384","phase":"PHASE4","title":"Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?","status":"RECRUITING","sponsor":"Christian Medical College, Vellore, India","startDate":"2025-02-15","conditions":"IgA Nephropathy, Renal Insufficiency, Chronic, IgA Vasculitis","enrollment":585},{"nctId":"NCT03354143","phase":"PHASE2","title":"Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2018-04-10","conditions":"Hypertension","enrollment":85},{"nctId":"NCT04864145","phase":"NA","title":"Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2021-05-21","conditions":"Aortic Valve Disease","enrollment":210},{"nctId":"NCT06930092","phase":"NA","title":"RestoratIon of Myocardial Function by PeRcutaneous cOronary interVEntion in Patients With Ischemic CardioMyoPathy","status":"RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2025-07-01","conditions":"Ischemic Cardiomyopathy","enrollment":158},{"nctId":"NCT07032116","phase":"","title":"YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study1","status":"NOT_YET_RECRUITING","sponsor":"Liu Hongfang","startDate":"2025-08-01","conditions":"Diabetic Kidney Disease (DKD)","enrollment":4472},{"nctId":"NCT03493685","phase":"PHASE3","title":"Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Travere Therapeutics, Inc.","startDate":"2018-04-17","conditions":"Focal Segmental Glomerulosclerosis","enrollment":371},{"nctId":"NCT04491136","phase":"PHASE4","title":"Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D (RHYTHM)","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2020-11-11","conditions":"Heart Failure","enrollment":201},{"nctId":"NCT01613118","phase":"PHASE2","title":"Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis","status":"COMPLETED","sponsor":"Travere Therapeutics, Inc.","startDate":"2014-03","conditions":"Focal Segmental Glomerulosclerosis","enrollment":109},{"nctId":"NCT06625346","phase":"","title":"Clinical Response of EXTOR (Amlodipine/Valsartan) in Newly Diagnosed Hypertensive Patients.","status":"RECRUITING","sponsor":"The Searle Company Limited Pakistan","startDate":"2024-09-28","conditions":"Hypertension","enrollment":420},{"nctId":"NCT03180450","phase":"PHASE1, PHASE2","title":"The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-HF)","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Heart Failure","enrollment":60},{"nctId":"NCT05637853","phase":"PHASE4","title":"Telemonitored Fast Track Medical Sequencing for Heart Failure With Reduced Ejection Fraction","status":"ACTIVE_NOT_RECRUITING","sponsor":"Göteborg University","startDate":"2022-10-22","conditions":"Heart Failure With Reduced Ejection Fraction","enrollment":60},{"nctId":"NCT04680442","phase":"PHASE2","title":"Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction","status":"RECRUITING","sponsor":"Population Health Research Institute","startDate":"2021-07-01","conditions":"Breast Cancer, Heart Failure","enrollment":130},{"nctId":"NCT06838416","phase":"","title":"Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease","status":"RECRUITING","sponsor":"Second Affiliated Hospital of Soochow University","startDate":"2023-11-17","conditions":"Type 2 Diabetes Mellitus, Chronic Kidney Disease, Renal Function","enrollment":300},{"nctId":"NCT05021419","phase":"NA","title":"Efficacy of a Streamlined Heart Failure Optimization Protocol","status":"COMPLETED","sponsor":"The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust","startDate":"2022-07-17","conditions":"Heart Failure with Reduced Ejection Fraction, Chronic Heart Failure","enrollment":60},{"nctId":"NCT00429364","phase":"PHASE3","title":"Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome","status":"COMPLETED","sponsor":"Carelon Research","startDate":"2007-01","conditions":"Marfan Syndrome","enrollment":608},{"nctId":"NCT02378805","phase":"","title":"Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome","status":"RECRUITING","sponsor":"University Hospital Goettingen","startDate":"1995-07","conditions":"Alport Syndrome, Hereditary Kidney Disease, Pediatric Kidney Disease","enrollment":800},{"nctId":"NCT03122834","phase":"","title":"Effect of Genetic Polymorphism on the Clinical Outcome of Patients With Heart Failure","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2020-04-15","conditions":"Heart Failure","enrollment":246},{"nctId":"NCT06655480","phase":"PHASE2","title":"Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF","status":"NOT_YET_RECRUITING","sponsor":"National Medical Research Center for Cardiology, Ministry of Health of Russian Federation","startDate":"2025-03-18","conditions":"HFpEF, LVDD, Myocardial Fibrosis","enrollment":50},{"nctId":"NCT06012487","phase":"PHASE1","title":"Correlates and Control of Blood Pressure Variability","status":"NOT_YET_RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2026-05-01","conditions":"Blood Pressure Variability","enrollment":10},{"nctId":"NCT03127631","phase":"NA","title":"A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients","status":"RECRUITING","sponsor":"McMaster University","startDate":"2015-10-21","conditions":"Prostate Cancer, Cardiovascular Disease","enrollment":6000},{"nctId":"NCT06794710","phase":"NA","title":"Early Identification and Treatment of Rare Cardiomyopathy Cohorts","status":"NOT_YET_RECRUITING","sponsor":"RenJi Hospital","startDate":"2025-02-01","conditions":"Hypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM), Metabolic Cardiomyopathy","enrollment":300},{"nctId":"NCT05759754","phase":"NA","title":"Effects of Traditional Chinese Medicine (GSJYF) in Children With Inherited Proteinuric Kidney Disease","status":"COMPLETED","sponsor":"Children's Hospital of Fudan University","startDate":"2023-09-17","conditions":"Proteinuria, Kidney Diseases, Hereditary Nephropathy","enrollment":72},{"nctId":"NCT06654596","phase":"NA","title":"Efficacy and Safety of Telitacicept in IgAN","status":"RECRUITING","sponsor":"Ruijin Hospital","startDate":"2024-12-06","conditions":"IgA Nephropathy (IgAN), Kidney Diseases, Telitacicept","enrollment":118},{"nctId":"NCT04913870","phase":"PHASE4","title":"Angiotensin Receptor Blockers in Aortic Stenosis","status":"RECRUITING","sponsor":"Institut universitaire de cardiologie et de pneumologie de Québec, University Laval","startDate":"2020-02-01","conditions":"Aortic Stenosis, Aortic Valve Stenosis","enrollment":144},{"nctId":"NCT06711432","phase":"NA","title":"Different Intraoperative Blood Pressure Management on Postoperative Cognitive Function in Tumor Patients（PRECISION）","status":"RECRUITING","sponsor":"Zhejiang Cancer Hospital","startDate":"2024-09-18","conditions":"Tumor, Stroke","enrollment":214},{"nctId":"NCT06608472","phase":"PHASE3","title":"Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension","status":"NOT_YET_RECRUITING","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-11-30","conditions":"Essential Arterial Hypertension","enrollment":292},{"nctId":"NCT04647396","phase":"NA","title":"Biomarker-guided Intervention to Prevent Acute Kidney Injury","status":"COMPLETED","sponsor":"University Hospital Muenster","startDate":"2020-11-17","conditions":"Acute Kidney Injury","enrollment":1180},{"nctId":"NCT00933231","phase":"PHASE3","title":"Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2009-08-17","conditions":"Kidney Transplantation","enrollment":281},{"nctId":"NCT02358096","phase":"PHASE2","title":"A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease","status":"COMPLETED","sponsor":"Astellas Pharma Europe B.V.","startDate":"2015-03-17","conditions":"Chronic Kidney Disease, Type 2 Diabetes","enrollment":125},{"nctId":"NCT05709444","phase":"PHASE2","title":"A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease","status":"COMPLETED","sponsor":"Palatin Technologies, Inc","startDate":"2022-12-26","conditions":"Kidney Disease","enrollment":16},{"nctId":"NCT06635616","phase":"","title":"Hypertension Management in Terms of Routine Agents","status":"NOT_YET_RECRUITING","sponsor":"Saglik Bilimleri Universitesi","startDate":"2024-11-01","conditions":"Hypertension, Emergency Medicine","enrollment":350},{"nctId":"NCT04053764","phase":"PHASE2","title":"Study Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell Disease","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2019-12-10","conditions":"Sickle Cell Disease (SCD)","enrollment":58},{"nctId":"NCT06604897","phase":"","title":"Effectiveness of Entresto (Sacubitril/Valsartan) in Japanese Patients With Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis","startDate":"2023-01-31","conditions":"Essential Hypertension","enrollment":1405},{"nctId":"NCT05824923","phase":"PHASE3","title":"A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure","status":"RECRUITING","sponsor":"Pulnovo Medical (Wuxi) Co., Ltd.","startDate":"2023-08-14","conditions":"Pulmonary Hypertension, Heart Failure With Reduced Ejection Fraction, Hypertension","enrollment":264},{"nctId":"NCT05419583","phase":"NA","title":"Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2022-11-14","conditions":"Myocardial Infarction Type 2","enrollment":60},{"nctId":"NCT05164653","phase":"PHASE4","title":"Program of Angiotensin-Neprilysin Inhibition in Admitted Patients With Worsening Heart Failure (PREMIER)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Saga University","startDate":"2021-12-27","conditions":"Heart Failure","enrollment":400},{"nctId":"NCT05169411","phase":"","title":"Preserving Kidney Function in Children With Chronic Kidney Disease","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2023-09-22","conditions":"Chronic Kidney Disease Stage 2, Chronic Kidney Disease Stage 3, Pediatric Kidney Disease","enrollment":20240},{"nctId":"NCT06515678","phase":"","title":"Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Groupe Hospitalier Pitie-Salpetriere","startDate":"2024-05-20","conditions":"Ovarian Cancer, Antiangiogenic-Associated Hypertension, Adjuvant Bevacizumab","enrollment":9464},{"nctId":"NCT06501651","phase":"PHASE4","title":"Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy","status":"NOT_YET_RECRUITING","sponsor":"Sichuan Academy of Medical Sciences","startDate":"2024-08-01","conditions":"Essential Hypertension, Type 2 Diabetes, Nephropathy","enrollment":297},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT05364190","phase":"PHASE3","title":"Canagliflozin in Patients With Acute Decompansted Heart Failure","status":"COMPLETED","sponsor":"October 6 University","startDate":"2022-06-04","conditions":"Chronic Heart Failure, Acute Heart Failure, Diabetes Mellitus","enrollment":142},{"nctId":"NCT05623358","phase":"NA","title":"PHARM Optimal-HF Pilot","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of British Columbia","startDate":"2023-03-13","conditions":"Heart Failure With Reduced Ejection Fraction","enrollment":42},{"nctId":"NCT04881123","phase":"PHASE2, PHASE3","title":"SER150 vs Placebo in Diabetic Kidney Disease","status":"COMPLETED","sponsor":"Serodus AS","startDate":"2021-08-18","conditions":"Diabetic Kidney Disease","enrollment":20},{"nctId":"NCT05269615","phase":"PHASE4","title":"Exercise-induced Erythropoiesis: the Mechanistic of Angiotensin II","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2023-03-20","conditions":"Exercise Physiology","enrollment":80},{"nctId":"NCT06395194","phase":"PHASE3","title":"Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"1997-09-27","conditions":"Essential Hypertension","enrollment":15313},{"nctId":"NCT06382571","phase":"","title":"Factors Associated With Sub - Targeted Therapeutic Dose Of Renin - Angiotensin Blockage Among Chronic Heart Failure With Reduced Ejection Fraction Patients","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2016-01-01","conditions":"Heart Failure With Reduced Ejection Fraction","enrollment":396},{"nctId":"NCT05818995","phase":"","title":"Therapeutic Drug Use for CKD Patients","status":"UNKNOWN","sponsor":"Qianfoshan Hospital","startDate":"2022-07-01","conditions":"Chronic Kidney Disease","enrollment":10000},{"nctId":"NCT02587936","phase":"NA","title":"Improving Chronic Disease Management With Pieces","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2016-07-18","conditions":"Chronic Kidney Disease, Diabetes, Hypertension","enrollment":18268},{"nctId":"NCT02597361","phase":"PHASE3","title":"Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome (ARCADE)","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-01","conditions":"Ehlers-Danlos Syndrome, Vascular Type","enrollment":61},{"nctId":"NCT06278727","phase":"","title":"Development and Validation of the Prediction Model for Functional Mitral Regurgitation Regression in Heart Failure Patients Taking Guideline-directed Medical Therapy","status":"UNKNOWN","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2024-01-01","conditions":"Mitral Regurgitation, Heart Failure","enrollment":270},{"nctId":"NCT05638880","phase":"PHASE2","title":"Clinical Study to Evaluate the Possible Efficacy and Safety of Levocetirizine in Patients With Diabetic Kidney Disease","status":"RECRUITING","sponsor":"Mostafa Bahaa","startDate":"2022-12-20","conditions":"Diabetic Nephropathies","enrollment":60},{"nctId":"NCT01563731","phase":"PHASE4","title":"Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives","status":"COMPLETED","sponsor":"Istituto Auxologico Italiano","startDate":"2013-04","conditions":"Stroke, Transient Ischemic Attack, Hypertension","enrollment":200},{"nctId":"NCT04371289","phase":"","title":"Predictors of Cardiovascular Risk in Covid-19 Patients During Acute Disease and at Short Term Follow-up","status":"COMPLETED","sponsor":"Istituto Auxologico Italiano","startDate":"2020-04-08","conditions":"COVID-19, Cardiovascular Risk Factor","enrollment":4356},{"nctId":"NCT00456963","phase":"PHASE4","title":"Prevention of Diabetes and Hypertension","status":"TERMINATED","sponsor":"Istituto Auxologico Italiano","startDate":"2007-09","conditions":"Diabetes Mellitus, Hypertension","enrollment":3000},{"nctId":"NCT06201000","phase":"","title":"Effect of Genetic Polymorphisms on the Clinical Response to SGLT2 Inhibitors in Heart Failure Patients","status":"UNKNOWN","sponsor":"October 6 University","startDate":"2023-12-27","conditions":"Genetic Polymorphisms, Heart Failure","enrollment":282},{"nctId":"NCT06218199","phase":"PHASE4","title":"Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts","status":"RECRUITING","sponsor":"Heart Center Research, LLC","startDate":"2021-07-08","conditions":"Heart Failure, Congestive","enrollment":80},{"nctId":"NCT02351063","phase":"NA","title":"HF Assessment With BNP in the Home: Part II","status":"TERMINATED","sponsor":"Alere San Diego","startDate":"2014-04","conditions":"Heart Failure","enrollment":1},{"nctId":"NCT06175663","phase":"","title":"Hyperintense: Midlife Hypertension and the Brain","status":"UNKNOWN","sponsor":"Radboud University Medical Center","startDate":"2021-07-06","conditions":"Hypertension, Small Vessel Cerebrovascular Disease","enrollment":130},{"nctId":"NCT03015974","phase":"","title":"Registry of IgA Nephropathy in Chinese Children","status":"UNKNOWN","sponsor":"Peking University First Hospital","startDate":"2016-01","conditions":"IgA Nephropathy, Proteinuria in Nephrotic Range, Immunosuppressive Treatment","enrollment":1200},{"nctId":"NCT05157464","phase":"PHASE4","title":"Losartan Use to Mitigate Arthrofibrosis Following Total Join Arthroplasty","status":"WITHDRAWN","sponsor":"NYU Langone Health","startDate":"2023-09-01","conditions":"Arthrofibrosis","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3728,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Candesartan, eprosartan, irbesartan, losartan, olmesartan, telmisartan, valsartan","Losartan"],"phase":"marketed","status":"active","brandName":"Angiotensin receptor blocker","genericName":"Angiotensin receptor blocker","companyName":"National University of Ireland, Galway, Ireland","companyId":"national-university-of-ireland-galway-ireland","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Angiotensin receptor blockers block the angiotensin II type 1 receptor, preventing vasoconstriction and aldosterone release to lower blood pressure. Used for Hypertension, Heart failure with reduced ejection fraction, Diabetic nephropathy.","enrichmentLevel":3,"visitCount":10,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}